HUTCHMED (China) Ltd (NASDAQ:HCM)
| 16.69 Delayed Data As of 3:59pm ET |  +0.48 / +2.96%Today’s Change | 7.39 Today|||52-Week Range 21.28 | +12.92% Year-to-Date |
Latest HCM News | Press Releases
| Is HUTCHMED (China) Ltd (HCM) Set to Underperform? Analyzing the Factors Limiting Growth Sep 25 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 16.21 |
| Today’s open | 16.75 |
| Day’s range | 16.57 - 16.96 |
| Volume | 8,752 |
| Average volume (3 months) | 112,126 |
| Market cap | $2.8B |
Data as of 3:59pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | -73.46% |
| Earnings growth (this year) | +69.37% |
| Earnings growth (next 5 years) | -10.93% |
| Revenue growth (last year) | +19.73% |
| P/E ratio | NM |
| Price/Sales | 5.87 |
| Price/Book | 4.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CYTKCytokinetics Inc | -0.10 | -0.33% |
| MRTXMirati Therapeutics ... | +0.55 | +1.35% |
| MDGLMadrigal Pharmaceuti... | +2.52 | +1.69% |
| ---- |
Data as of 3:59pm ET, 09/27/2023
Financials
| Last reporting date | June 1, 2022 |
| EPS forecast (this quarter) | -$0.70 |
| Annual revenue (last year) | $426.4M |
| Annual profit (last year) | -$360.8M |
| Net profit margin | -84.62% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
